Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Vaccines|June 2, 2021
Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons LearnedCéline H Lemoine, Reviany V Nidom, Roland Ventura, et al.
Frontiers in Immunology|September 19, 2022
Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccineJake S O'Donnell, Ariel Isaacs, Virginie Jakob, et al.
Vaccine|February 11, 2015
TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and developmentMark J Geels, Regitze L Thøgersen, Carlos A Guzman, et al.
Vaccine|April 5, 2026
Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccinationJean-Claude Sirard, Delphine Cayet, Delphine Fougeron, et al.
Mbio|March 12, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A <i>Streptococcus</i> Infection in the Absence of Opsonizing AntibodiesTania Rivera-Hernandez, Mira Syahira Rhyme, Amanda J Cork, et al.
NPJ Vaccines|February 23, 2019
Erratum: Author Correction: System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheepRoman Othmar Braun, Livia Brunner, Kurt Wyler, et al.
NPJ Vaccines|October 11, 2018
System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheepRoman Othmar Braun, Livia Brunner, Kurt Wyler, et al.
Vaccines|February 10, 2021
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of AdministrationChristoph M Janitzek, Philip H R Carlsen, Susan Thrane, et al.
The Journal of Infectious Diseases|November 26, 2013
Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureusKaren Misstear, Edel A McNeela, Alison G Murphy, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
Pageof 6